AEON Biopharma
AEON
AEON
37 hedge funds and large institutions have $4.8M invested in AEON Biopharma in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less capital invested
Capital invested by funds: $10.1M → $4.8M (-$5.25M)
Holders
37
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$242K | |
| 2 | +$40.4K | |
| 3 | +$30.7K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$19.9K |
| 5 |
HF
HRT Financial
New York
|
+$16.7K |
Top Sellers
| 1 | -$677K | |
| 2 | -$236K | |
| 3 | -$12.5K | |
| 4 |
Two Sigma Investments
New York
|
-$9.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.11K |